BACKGROUND AND OBJETIVE: Familial hypobetalipoproteinemia (FHB) is usually due to mutations in the APOB gene. Almost 60 different mutations have been reported. We report a Spanish family with FHB phenotype and a new mutation. PATIENT AND METHODS: We performed an analytical, localizing and molecular study of the APOB gene in the proband and in two relatives phenotypically affected. RESULTS: The proband was a 32-year-old woman with moderate to severe mental retardation, morbid obesity, hypocholesterolemia, hypertransaminasemia, and hepatic steatosis. The familial phenotypic study was positive in other 6 relatives. The genetic study confirmed the presence of a novel mutation (apoB-69.27) in the APOB gene. The proband, her mother and one maternal great aunt were heterozygote for that mutation. CONCLUSIONS: FHB has a variable phenotypic expression that can range from oligosymptomatic disease to severe neurological damage.
Familial hypobetalipoproteinemia: clinical characterization of a new mutation in the APOB gene / Iglesias, P; Díez, Jj; Tarugi, Patrizia Maria. - In: MEDICINA CLINICA. - ISSN 0025-7753. - STAMPA. - 133 (2):2(2009), pp. 57-60. [10.1016/j.medcli.2008.10.063]
Familial hypobetalipoproteinemia: clinical characterization of a new mutation in the APOB gene
TARUGI, Patrizia Maria
2009
Abstract
BACKGROUND AND OBJETIVE: Familial hypobetalipoproteinemia (FHB) is usually due to mutations in the APOB gene. Almost 60 different mutations have been reported. We report a Spanish family with FHB phenotype and a new mutation. PATIENT AND METHODS: We performed an analytical, localizing and molecular study of the APOB gene in the proband and in two relatives phenotypically affected. RESULTS: The proband was a 32-year-old woman with moderate to severe mental retardation, morbid obesity, hypocholesterolemia, hypertransaminasemia, and hepatic steatosis. The familial phenotypic study was positive in other 6 relatives. The genetic study confirmed the presence of a novel mutation (apoB-69.27) in the APOB gene. The proband, her mother and one maternal great aunt were heterozygote for that mutation. CONCLUSIONS: FHB has a variable phenotypic expression that can range from oligosymptomatic disease to severe neurological damage.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris